Primary chemotherapy in breast cancer shows excellent clinical and pathological response with docetaxel and epirubicin by Marana, H.R.C., Andrade, J.M., Tiezzi, D.G., Taborda, M.F., Machetti, A.H., Carrara, H.H.A., Reis, F.J.C., Bighetti, S.

Get full text